Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: Major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines

Immunology

Volumn 119, Issue 1, 2006, Pages 98-115

  Koch, Katherine S ^a   Son, Kyung Hwa ^a   Maehr, Rene ^b   Pellicciotta, Illenia ^c   Ploegh, Hidde L ^b   Zanetti, Maurizio ^c   Sell, Stewart ^d   Leffert, Hyam L ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d WADSWORTH CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune privilege; Progenitor cell phenotypes

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CD95L ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; DIFFERENTIATION ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PADGEM PROTEIN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; FLOW CYTOMETRY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; STEM CELL; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BETA 2-MICROGLOBULIN; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENES, MHC CLASS I; GENES, MHC CLASS II; H-2 ANTIGENS; HAPLOTYPES; HUMANS; INTERFERON TYPE II; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; STEM CELLS;

EID: 33746919556     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02412.x     Document Type: Article

References (74)

1. Auchincloss H Jr. In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 2001; 1:6-12.
2. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001; 344:655-64.
3. Bellingham RE, Brent L, Medawar PB. 'Actively acquired tolerance' of foreign cells. Nature 1953; 172:603-6.
4. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Mosely AM, Deans R, Marshak DR, Flake AW. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Med 2000; 6:1282-6.
5. Taylor AW, Streilein JW. Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation 1996; 3:112-8.
6. Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J Invest Dermatol Symp Proc 2003; 8:168-72.
7. Hoglund P, Karre K, Klein G. The uterine cervix - a new member of the family of immunologically exceptional sites? Cancer Immunol 2003; 3:6.
8. Guller S, LaChapelle L. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin Reprod Endocrinol 1999; 17:39-44.
9. Ferguson TA, Griffith TS. A vision of cell death: insights into immune privilege. Immunol Rev 1997; 156:167-84.
10. Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol 2002; 21:153-72.
11. Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation. Past, present and future. Semin Nephrol 2000; 20:108-25.
12. Krensky AM, Strom TB, Bluestone JA. Immunomodulators: immunosuppressive agents, tolerogens, and immunostimulants. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn. New York: McGraw-Hill, 2001:1463-84.
13. Rhind SM, Taylor JE, De Sousa PA, King TJ, McGarry M, Wilmut I. Human cloning: can it be made safe? Nat Rev Genet 2003; 4:855-64.
14. Fairchild PJ, Cartland S, Nolan KF, Waldmann H. Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol 2004; 25:465-70.
15. Surani MA. Nuclear reprogramming by human embryonic stem cells. Cell 2005; 122:653-4.
16. Chung Y, Klimanskaya I, Becker S, Marh J, Lu S-J, Johnson J, Meisner L, Lanza R. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 2006; 439:216-19.
17. Meissner A, Jaenisch R. Generation of nuclear-transfer derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 2006; 439:212-15.
18. Saito T, Kuang JQ, Bittera B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002; 74:19-24.
19. Hori J, Ng TF, Shatos M, Klassen H, Streilen JW, Young MJ. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003; 21:405-16.
20. Abraham EJ, Kodama S, Lin JC, Ubeda M, Faustman DL, Habener JF. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol 2004; 164:817-30.
21. Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22:448-56.
22. Mansilla E, Marin GH, Sturla F et al. Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplantation Proc 2005; 37:292-4.
23. Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells 2006; 24:221-29.
24. Zhang M, Joseph B, Gupta S et al. Embryonic mouse STO cell-derived xenografts express hepatocytic functions in the livers of non-immunosuppressed adult rats. Stem Cells 2005; 23:186-99.
25. Anderson CC, Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med 2001; 7:80-7.
26. Ying Q-L, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002; 416:545-8.
27. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416:542-5.
28. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422:897-901.
29. Vassilopoulos G, Wang P-R, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422:901-4.
30. Zhang M, Sell S, Leffert HL. Hepatic progenitor cell lines from allyl alcohol-treated adult rats are derived from γ-irradiated mouse STO cells. Stem Cells 2003; 21:449-58.
31. Meagher S, Potts WK. A microsatellite-based MHC genotyping system for house mice (Mus domesticus). Hereditas 1997; 127:75-82.
32. Ware LM, Axelrad AA. Inherited resistance to N- and B tropic murine leukemia viruses in vitro: evidence that congenic mouse strains SIM and SIM.R differ at the Fv-1 locus. Virology 1972; 50:339-48.
33. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MFW, Fisher EMC. Genealogies of mouse inbred strains. Nature Gen 2000; 24:23-5.
34. Warner CM, Almquist CD, Toulimat MH, Xu Y. Induction of embryonic major histocompatibility complex antigen expression by gamma-IFN. J Reprod Immunol 1993; 24:111-21.
35. Krause DS, Fackler MJ, Civin CI, May WS. CD34: Structure, biology, and clinical utility. Blood 1996; 87:1-13.
36. Huntington ND, Tarlinton DM. CD45: direct and indirect government of immune regulation. Immunol Lett 2004; 94:167-74.
37. Roskoski R Jr. Signaling by Kit protein-tyrosine kinase - the stem cell factor receptor. Biochem Biophys Res Commun 2005; 337:1-13.
38. Maher S, Toomey D, Condron C, Bouchier-Hayes D. Activation-induced cell death. The controversial role of Fas and Fas ligand in immune privilege and tumor counterattack Immunol Cell Biol 2002; 80:131-7.
39. Askenasy N, Yolcu ES, Yaniv I, Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 2005; 105:1396-404.
40. Zellweger R, Ayala A, DeMaso CM, Chaudry IH. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995; 4:149-53.
41. Gerloni M, Castiglioni P, Zanetti M. The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice. J Immunol 2005; 175:6551-9.
42. Lu XP, Koch KS, Lew DJ, Dulic V, Pines J, Reed SI, Hunter T, Leffert HL. Induction of cyclin mRNA and histone H1-kinase during liver regeneration. J Biol Chem 1992; 267:2841-4.
43. Smith MJ, Parker JMR, Hodges RS, Barber BH. The preparation and characterization of anti-peptide heteroantisera recognizing subregions of the intracytoplasmic domain of class I H-2 antigens. Mol Immunol 1986; 23:1077-92.
44. Machold RP, Ploegh HL. Intermediates in the assembly and degradation of class I major histocompatibility complex (MHC) molecules probed with free heavy chain-specific monoclonal antibodies. J Exp Med 1996; 184:2251-9.
45. d mutant molecules is reflected in their peptide binding properties. Eur J Immunol 1999; 29:2729-39.
46. Wang M, Stepkowski SM, Hebert JS, Tian LYuJ, Kahan BD. Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins. Ann Transplant 1996; 1:26-31.
47. Rubocki RJ, Lee DR, Lie WR, Myers NB, Hansen TH. Molecular evidence that the H-2D and H-2L genes arose by duplication. Differences between the evolution of the class I genes in mice and humans. J Exp Med 1990; 171:2043-61.
48. b-/-deficient mice possess functional CD8+ T cells and natural killer cells. Proc Natl Acad Sci USA 1988; 95:12492-7.
49. Haeryfar SM, Hoskin DW. Thy-1: more than a mouse pan-T cell marker. J Immunol 2004; 173:3581-8.
50. Rosen SD. Ligands for 1-selectin. Homing, inflammation, and beyond. Annu Rev Immunol 2004; 22:129-56.
51. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:515-48.
52. Martin GR, Evans MJ. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci USA 1975; 72:1441-5.
53. Lim JWE, Bodnar A. Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2002; 2:1187-203.
54. Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the MHC class I peptide loading complex. Immunol Rev 1999; 172:21-8.
55. Eisen Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996; 4:565-71.
56. d antigens. Z Immun-Forsch Bd 1974; 148:45-61.
57. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA 2004; 101(Suppl. 2):14607-14.
58. Sriwatanawongsa V, Davies HS, Calne RW. The essential roles of parenchymal cells and passenger leukocytes in the tolerance induced by liver grafting in rats. Nature Med 1995; 1:428-32.
59. Abbas AK, Lichtman AH. Basic Immunology. Functions and Disorders of the Immune System. Philadelphia: W. B. Saunders, 2001.
60. Rao SO, Starzl TE, Demetris AJ, Trucco M, Thomson A, Qian S, Murase N, Fung JJ. The two-way paradigm of transplantation immunology. Clin Immunol Immunopath 1996; 80:S46-S51.
61. Collins M, Ling V, Carreno BM. The B7 family of immuneregulatory ligands. Genome Biol 2005; 6:223.1-223.7.
62. Ding H, Wu X, Gao W. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Clin Immunol 2005; 115:184-91.
63. Khayyamian S, Hutloff A, Buchner K, Grafe M, Henn V, Kroczek RA, Mages HW. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci USA 2002; 99:6198-203.
64. Pan TL, Goto S, Lin YC et al. The Fas and Fas ligand pathways in liver allograft tolerance. Clin Exp Immunol 1999; 118:180-7.
65. Lee H, Ferguson TA. Biology of FasL. Cytokine Growth Factor Rev 2003; 14:325-35.
66. Barry FP, Murphy JM, English K, Mahon BP. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev 2005; 14:252-65.
67. Silverman T, Rein A, Orrison B, Langloss J, Bratthauer G, Miyazaki J, Ozato K. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells. J Immunol 1988; 140:4378-87.
68. Ozato K, Wan YJ, Orrison BM. Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci USA 1985; 82:2427-31.
69. Lin G, Finger E, Gutierrez-Ramos JC. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol 1995; 25:508-16.
70. Ntambi JN, Kim YC. Adipocyte differentiation and gene expression. J Nutr 2000; 130:3122S-26S.
71. Rao MS, Civin CI. Translational Research: Toward better characterization of human embryonic stem cell lines. Stem Cells 2005; 23:1453.
72. Tsuchiya A, Heike T, Fujino H et al. Long-term extensive expansion of mouse hepatic stem/progenitor cells in a novel serumfree culture system. Gastroenterology 2005; 128:2089-104.
73. Li WL, Su J, Yao YC et al. Isolation and characterization of bipotent liver progenitor cells from adult mouse. Stem Cells 2006; 24:322-32.
74. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263:17755-62.